Oral melatonin in high-risk critically ill patients: quality of sedative effect
Giovanni Sabbatini(University of Milan), G. Iapichino(University of Milan), Sara Miori(University of Milan), Chiara Villa(Centre National de la Recherche Scientifique), I. Galluccio(University of Milan), B Cerri(University of Milan), Meghan Tozzi(University of Milan), Giovanni Mistraletti, F. Fraschini(University of Milan), Michele Umbrello(Azienda Ospedaliera Ospedale Civile di Legnano)
Cited by 2
Related Papers
A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study
|Intensive Care Medicine|2009|906
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study
|The Journal of Clinical Endocrinology & Metabolism|2010|374
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
|Endocrine Related Cancer|2017|357
Gigantism and Acromegaly Due to Xq26 Microduplications and <i>GPR101</i> Mutation
|New England Journal of Medicine|2014|340
Pangenomic Classification of Pituitary Neuroendocrine Tumors
|Cancer Cell|2019|335